How many clinical trials are tracked of roflumilast?

23 trials are tracked, 4 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

roflumilast

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of roflumilast

23 trials tracked of roflumilast: 14 in phase 3 or 4 and 4 with published results. The most-cited published study has 125 citations.

23Trials tracked

14Phase 3 & 4

0Recruiting

4With published results

Phase distribution

Phase 4 5 Phase 3 9 Phase 2 4 Phase 1 4 Other / NA 1

Phase 4 Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS) Completed · 125 cited
Phase 3 Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary Disease Completed · 60 cited
Phase 3 Evaluation of Tolerability and Pharmacokinetics of Roflumilast, 250μg and 500μg, as add-on to Standard COPD Treatment to Treat Severe COPD Completed · 13 cited
Phase 4 Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD) Completed · 4 cited
Phase 4 The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis Completed
Phase 4 Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD Completed

Show 17 more trials

Phase 4 Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS) Completed
Phase 3 Enhancement of Corticosteroid Efficacy in COPD Completed
Phase 3 Effects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalization Completed
Phase 3 Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124) Completed
Phase 3 Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125) Completed
Phase 3 A Chronic Obstructive Pulmonary Disease (COPD) Trial Investigating Roflumilast on Safety and Effectiveness in China, Hong Kong and Singapore: Completed
Phase 3 Effect of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Tiotropium: The HELIOS Study (BY217/M2-128) Completed
Phase 3 Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127) Completed
Phase 2 Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis Completed
Phase 2 Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals Completed
Phase 2 Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD Completed
Phase 2 Roflumilast Plus Montelukast in Adults With Severe Asthma Completed
Phase 1 Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes Completed
Phase 1 Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia Completed
Phase 1 Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults Completed
Phase 1 Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013) Completed
N/A A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD) Completed

Showing the 23 most-cited and recently-updated of 23 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.